Cargando…

Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database

Background: It is thought that older patients with multiple sclerosis (MS) may present with a different clinical disease phenotype, and therefore respond to subcutaneous interferon beta-1a (sc IFN β-1a) differently to younger patients. However, few real-world data are available concerning the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allignol, Arthur, Boutmy, Emmanuelle, Sabidó Espin, Meritxell, Marhardt, Kurt, Vermersch, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351462/ https://www.ncbi.nlm.nih.gov/pubmed/34381411 http://dx.doi.org/10.3389/fneur.2021.676585

Ejemplares similares

Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study
por: Sabidó-Espin, Meritxell, et al.
Publicado: (2017)

Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events
por: Foch, Caroline, et al.
Publicado: (2022)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a
por: Hupperts, Raymond, et al.
Publicado: (2019)

Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
por: Nørgaard, Mette, et al.
Publicado: (2021)

Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance
por: Sabidó, Meritxell, et al.
Publicado: (2018)

The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis
por: Burkill, Sarah, et al.
Publicado: (2019)

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
por: Edo Solsona, María Dolores, et al.
Publicado: (2017)

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study
por: Cohan, Stanley, et al.
Publicado: (2018)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects
por: Hu, Xiao, et al.
Publicado: (2016)

Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database
por: Brand, Kerstin M G, et al.
Publicado: (2022)

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device
por: Willis, Helen, et al.
Publicado: (2014)

Data resource profile: JMDC claims databases sourced from Medical Institutions
por: Nagai, Katsuhiko, et al.
Publicado: (2020)

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial
por: Wilkinson, Tom
Publicado: (2021)

Efficacy of subcutaneous interferon-beta in COVID-19: a meta-analysis and systematic review
por: Asif, Abuzar A., et al.
Publicado: (2021)

Evolution of the RebiSmart(®) Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
por: Lin, Yu-Ting, et al.
Publicado: (2023)

Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
por: Kirkman, M. Sue, et al.
Publicado: (2015)

Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database
por: Ishida, Takayuki, et al.
Publicado: (2018)

Data resource profile: JMDC claims database sourced from health insurance societies
por: Nagai, Katsuhiko, et al.
Publicado: (2021)

Naked barley—Optimized recipe for pure barley bread with sufficient beta-glucan according to the EFSA health claims
por: Kinner, M., et al.
Publicado: (2011)

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)
por: Pedersen, Elena Didenko, et al.
Publicado: (2018)

Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
por: Hakkarainen, Katja Marja, et al.
Publicado: (2020)

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis
por: Freedman, Mark S., et al.
Publicado: (2021)

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
por: Moccia, Marcello, et al.
Publicado: (2020)

Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization: Analysis of a medical claims database
por: Mohamad Al-Ali, Badereddin, et al.
Publicado: (2016)

Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications
por: Ooba, Nobuhiro, et al.
Publicado: (2013)

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
por: Bloomgren, Gary, et al.
Publicado: (2012)

Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma
por: Fukuda, Haruhisa, et al.
Publicado: (2020)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart(®) Injector: Results of the Prospective Cohort Study REBIFLECT
por: Rieckmann, Peter, et al.
Publicado: (2022)

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
por: Hellwig, Kerstin, et al.
Publicado: (2020)

Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta
por: Zecca, Chiara, et al.
Publicado: (2014)

Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study
por: Bergvall, Niklas, et al.
Publicado: (2014)

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis
por: Kalincik, Tomas, et al.
Publicado: (2013)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

Adherence and Persistence with First-Line Therapy and Compliance with Glaucoma Guidelines Using Japanese Health Care/Pharmacy Claims Database
por: Shirai, Chikako, et al.
Publicado: (2021)

Sub-Optimal Adherence With Daily Growth Hormones Increases With Each Year of Treatment in a US Commercial Claims Database
por: Loftus, Jane, et al.
Publicado: (2021)

Pediatric endoscopic subcutaneous mastectomy (pesma) with liposuction in adolescents with gynecomastia
por: Varlet, François, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_io9rgnsvbs01lj3sobv5nn7979